Inspire Medical pre-announces Q2 revenue $195.9M (+30% YoY), raises 2024 guidance to $788-798M

Inspire Medical Systems, Inc.

2024-Q2 EPS reported -$0.01 revenue$359,895,000

Q2 revenue $195.9M, up 30% YoY; US revenue $187.8M (+30%), OUS $8.1M (+27%).
Full-year 2024 revenue guidance raised to $788-798M, up $13M from prior $775-785M range.
Management cites strong execution and sequential US revenue growth acceleration.
Complete Q2 results and earnings call scheduled for August 6, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.